Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 96

1.

Neuroblastoma in monozygotic twins with distinct presentation pathology and outcome: is it familial or in utero metastasis.

Abu-Arja R, Hashem H, El-Sheikh A, Abusin G.

Pediatr Blood Cancer. 2014 Jun;61(6):1124-5. doi: 10.1002/pbc.24906. Epub 2013 Dec 23. Review.

PMID:
24376049
[PubMed - indexed for MEDLINE]
2.

A systematic review of 131I-meta iodobenzylguanidine molecular radiotherapy for neuroblastoma.

Wilson JS, Gains JE, Moroz V, Wheatley K, Gaze MN.

Eur J Cancer. 2014 Mar;50(4):801-15. doi: 10.1016/j.ejca.2013.11.016. Epub 2013 Dec 12. Review.

PMID:
24333097
[PubMed - indexed for MEDLINE]
3.

Neuroblastoma and MYCN.

Huang M, Weiss WA.

Cold Spring Harb Perspect Med. 2013 Oct 1;3(10):a014415. doi: 10.1101/cshperspect.a014415. Review.

PMID:
24086065
[PubMed - indexed for MEDLINE]
4.

Olfactory neuroblastoma (esthesioneuroblastoma): towards minimally invasive surgery and multi-modality treatment strategies - an updated critical review of the current literature.

Papacharalampous GX, Vlastarakos PV, Chrysovergis A, Saravakos PK, Kotsis GP, Davilis DI.

J BUON. 2013 Jul-Sep;18(3):557-63. Review.

PMID:
24065464
[PubMed - indexed for MEDLINE]
5.

High-dose chemotherapy and autologous haematopoietic stem cell rescue for children with high-risk neuroblastoma.

Yalçin B, Kremer LC, Caron HN, van Dalen EC.

Cochrane Database Syst Rev. 2013 Aug 22;8:CD006301. doi: 10.1002/14651858.CD006301.pub3. Review.

PMID:
23970444
[PubMed - indexed for MEDLINE]
6.

New strategies in neuroblastoma: Therapeutic targeting of MYCN and ALK.

Barone G, Anderson J, Pearson AD, Petrie K, Chesler L.

Clin Cancer Res. 2013 Nov 1;19(21):5814-21. doi: 10.1158/1078-0432.CCR-13-0680. Epub 2013 Aug 21. Review.

PMID:
23965898
[PubMed - indexed for MEDLINE]
Free PMC Article
7.

Current and future strategies for relapsed neuroblastoma: challenges on the road to precision therapy.

Morgenstern DA, Baruchel S, Irwin MS.

J Pediatr Hematol Oncol. 2013 Jul;35(5):337-47. doi: 10.1097/MPH.0b013e318299d637. Review.

PMID:
23703550
[PubMed - indexed for MEDLINE]
8.

Neuroblastoma: developmental biology, cancer genomics and immunotherapy.

Cheung NK, Dyer MA.

Nat Rev Cancer. 2013 Jun;13(6):397-411. doi: 10.1038/nrc3526. Review.

PMID:
23702928
[PubMed - indexed for MEDLINE]
9.

The mTOR signaling pathway in pediatric neuroblastoma.

Mei H, Wang Y, Lin Z, Tong Q.

Pediatr Hematol Oncol. 2013 Oct;30(7):605-15. doi: 10.3109/08880018.2013.798058. Epub 2013 May 22. Review.

PMID:
23697980
[PubMed - indexed for MEDLINE]
10.

Emerging drugs for neuroblastoma.

Castel V, Segura V, Berlanga P.

Expert Opin Emerg Drugs. 2013 Jun;18(2):155-71. doi: 10.1517/14728214.2013.796927. Epub 2013 May 22. Review.

PMID:
23692586
[PubMed - indexed for MEDLINE]
11.

Aiming at neuroblastoma and hitting other worthy targets.

Schor NF.

J Child Neurol. 2013 Jun;28(6):768-73. doi: 10.1177/0883073813483173. Epub 2013 Apr 10. Review.

PMID:
23576410
[PubMed - indexed for MEDLINE]
12.

Optimization of molecular radiotherapy with [131I]-meta Iodobenzylguanidine for high-risk neuroblastoma.

Gaze MN, Gains JE, Walker C, Bomanji JB.

Q J Nucl Med Mol Imaging. 2013 Mar;57(1):66-78. Review.

PMID:
23474636
[PubMed - indexed for MEDLINE]
13.

131I-Metaiodobenzylguanidine therapy in children with advanced neuroblastoma.

DuBois SG, Matthay KK.

Q J Nucl Med Mol Imaging. 2013 Mar;57(1):53-65. Review.

PMID:
23474635
[PubMed - indexed for MEDLINE]
14.

Contemporary approach to diagnosis and treatment of neuroblastoma.

Charron M.

Q J Nucl Med Mol Imaging. 2013 Mar;57(1):40-52. Review.

PMID:
23474634
[PubMed - indexed for MEDLINE]
15.

PET/CT imaging in neuroblastoma.

Piccardo A, Lopci E, Conte M, Foppiani L, Garaventa A, Cabria M, Villavecchia G, Fanti S, Cistaro A.

Q J Nucl Med Mol Imaging. 2013 Mar;57(1):29-39. Review.

PMID:
23474633
[PubMed - indexed for MEDLINE]
16.

Comparison of [123I]MIBG and [131I]MIBG for imaging of neuroblastoma and other neural crest tumors.

Liu B, Zhuang H, Servaes S.

Q J Nucl Med Mol Imaging. 2013 Mar;57(1):21-8. Review.

PMID:
23474632
[PubMed - indexed for MEDLINE]
17.

Functional-metabolic imaging of neuroblastoma.

Sharp SE, Parisi MT, Gelfand MJ, Yanik GA, Shulkin BL.

Q J Nucl Med Mol Imaging. 2013 Mar;57(1):6-20. Review.

PMID:
23474631
[PubMed - indexed for MEDLINE]
18.

Neuroblastoma in an adult: case presentation and literature review.

Smith L, Minter S, O'Brien P, Kraveka JM, Medina AM, Lazarchick J.

Ann Clin Lab Sci. 2013 Winter;43(1):81-4. Review.

PMID:
23462610
[PubMed - indexed for MEDLINE]
19.

Targeted immunotherapy for high-risk neuroblastoma--the role of monoclonal antibodies.

Parsons K, Bernhardt B, Strickland B.

Ann Pharmacother. 2013 Feb;47(2):210-8. doi: 10.1345/aph.1R353. Epub 2013 Feb 5. Review.

PMID:
23386066
[PubMed - indexed for MEDLINE]
20.

Outcome of neuroblastoma in India.

Kulkarni KP, Marwaha RK.

Indian J Pediatr. 2013 Oct;80(10):832-7. doi: 10.1007/s12098-012-0948-9. Epub 2013 Jan 23. Review.

PMID:
23340984
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk